Viatris Inc. - Common Stock (NQ:VTRS)

18.70 +0.41 (+2.24%)

Delayed Quote Updated: 1:20 PM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viatris Inc. - Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

BioAtla Announces Change in Executive Leadership

February 27, 2023

From BioAtla, Inc.

Via GlobeNewswire

2 Dividend Stocks to Buy at a Discounted Price In 2023 ↗

February 27, 2023

Their shares are ripe for getting while the getting is good.

Via The Motley Fool

Nasdaq, S&P 500 Futures Rebound In New Trading Week But Rising Bond Yields Remain A Risk ↗

February 27, 2023

US stocks are coming off a lackluster week and early indications suggest a reversal in sentiment in the new trading week. While rising bond yields could be a cause of concern, the recent weakness could...

Via Benzinga

2 Superb Dividend Stocks to Buy Before the Next Bull Market ↗

February 21, 2023

There might not be an opportunity to get them for much cheaper than now.

Via The Motley Fool

BMO Downgrades Viatris As Its Looks For More Visibility On Next Phase ↗

February 17, 2023

Via Benzinga

Where Viatris Stands With Analysts ↗

January 27, 2023

Via Benzinga

Stock Analysis: Viatris ↗

January 24, 2023

In the past year, Viatris’s share price dropped by $2.76, or about 19%.

Via Talk Markets

Golden Cross Appears Before Viatris Investors ↗

December 15, 2022

Via Benzinga

Earnings Scheduled For February 27, 2023 ↗

February 27, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.

Via Benzinga

Earnings Preview: Viatris ↗

February 24, 2023

Via Benzinga

3 Dirt-Cheap Stocks to Buy Sooner Rather Than Later ↗

February 18, 2023

These pharmaceutical stocks probably won't stay so attractively valued for too much longer.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2023 ↗

February 17, 2023

Via Benzinga

NVIDIA To Rally Around Over 30%? Here Are 10 Other Analyst Forecasts For Friday ↗

February 17, 2023

Keybanc boosted the price target for NVIDIA Corporation (NASDAQ: NVDA) from $220 to $280. Keybanc analyst John Vinh maintained an Overweight rating on the stock. NVIDIA shares fell 1.7% to $216.22 in...

Via Benzinga

These Are 3 of the Nasdaq's Cheapest Dividend Stocks ↗

February 15, 2023

These stocks can be good options whether you value dividends or growth.

Via The Motley Fool

3 Healthcare Stocks That Are Too Cheap to Ignore ↗

February 09, 2023

Pay attention when stocks have these kinds of low valuations.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023 ↗

January 27, 2023

Via Benzinga

2 Superb Dividend Stocks to Buy Today and Hold Forever ↗

January 24, 2023

These two companies have long runways for growth and decent yields today.

Via The Motley Fool

3 Dividend Stocks That Are Ridiculously Cheap Right Now ↗

January 20, 2023

Their valuations are low and their yields are high.

Via The Motley Fool

Could This New Drug Launch Be a Hit for Viatris? ↗

January 12, 2023

Viatris and Kindeva Drug Delivery could soon launch a generic version of AstraZeneca's Symbicort.

Via The Motley Fool

Is Now the Time to Buy 3 of the S&P 500's Cheapest Stocks? ↗

January 04, 2023

All of these stocks are trading at less than 7 times their future profits.

Via The Motley Fool

Why These 7 Healthcare Stocks Could Soar in 2023 ↗

January 02, 2023

These healthcare stocks to buy are trading at a hefty discount and are poised to deliver robust returns in 2023.

Via InvestorPlace

Could This Drug News Give a Lift to Eli Lilly Stock? ↗

January 01, 2023

In November, Eli Lilly received positive news from the U.S. Food and Drug Administration.

Via The Motley Fool

1 Passive Income Stock to Buy While It's Cheap and 1 to Avoid ↗

December 29, 2022

Both businesses are well-suited for producing passive income, but only one has the balance sheet and future prospects to make it work.

Via The Motley Fool

3 High-Yielding Dividend Stocks That Could See Hikes in January ↗

December 29, 2022

These stocks all pay more than 3% in dividends.

Via The Motley Fool

'Sell The Darlings, Own The Dogs': Why It May Soon Be Time To Buy Tesla, Meta And Other Worst-Performing Stocks Of 2022 ↗

December 28, 2022

Via Benzinga

The 7 Best Crypto and Stocks to Buy as Christmas Gifts This Year ↗

December 21, 2022

These stocks to buy as Christmas gifts provide a number of reasons for investors to rejoice this holiday season.

Via InvestorPlace

2 Mammoth Stocks With Dividends to Buy Before 2022 Ends ↗

December 21, 2022

Blue chip healthcare stocks Johnson & Johnson and Cigna are always in season.

Via The Motley Fool

The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond ↗

December 18, 2022

These seven hottest healthcare stocks have strong growth catalysts that could send each of them higher over the next few years.

Via InvestorPlace

Want $3,000 in Dividend Income Next Year? Invest $50,000 in These 2 Stocks ↗

December 07, 2022

These stocks have dividend yields exceeding 4%.

Via The Motley Fool

Better Dividend Stock: AbbVie or Viatris? ↗

November 26, 2022

These pharmaceutical companies are profitable and offer above-average dividends.

Via The Motley Fool

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.